| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. | Director | Common Stock | 16.5K | $378K | $23.00 | Apr 1, 2023 | Direct |
| Personalis, Inc. | Director | Stock Option (right to buy) | 40K | May 17, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | Director |
| PSNL | Personalis, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 0 | $0 | 3 | May 4, 2023 | Director |
| HARP | Harpoon Therapeutics, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| HARP | Harpoon Therapeutics, Inc. | Jun 22, 2022 | 2 | $40K | 4 | Jun 24, 2022 | Director |
| PSNL | Personalis, Inc. | May 17, 2022 | 2 | $0 | 4 | May 19, 2022 | Director |
| PSNL | Personalis, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |
| HARP | Harpoon Therapeutics, Inc. | May 4, 2021 | 0 | $0 | 4/A | May 14, 2021 | Director |